EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access

Hyalinizing Clear Cell Carcinoma of the Head and Neck: A Multicenter Retrospective Study of 87 Cases Focusing on Prognostic Pathologic Features and Grading Scheme

Bin Xu, Kartik Viswanathan, Marie Barbesier, Alexander Ladenheim, Cristina R Antonescu, Ronald Ghossein, Dan Lubin, Kelly Magliocca, Sayed Matar, Michael W Mikula, Isabella Tondi Resta, Dibisha Roy und 7 weitere

Modern Pathology · 2025

DOI: 10.1016/j.modpat.2025.100834 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Modern Pathology, 2025. Verfasst von Bin Xu und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. Hauptthemen laut MEDLINE: Adenocarcinoma, Clear Cell, Salivary Gland Neoplasms, Head and Neck Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, National Institutes of Health, National Institutes of Health National Cancer Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hyalinizing clear cell carcinoma (HCCC) is a salivary gland carcinoma characterized by the presence of clear and eosinophilic cells within a hyalinized stroma and the EWSR1 rearrangement. Aiming to identify prognostic factors and establish a grading system, we herein conducted a detailed clinicopathology review of a large retrospective cohort of 87 HCCCs from 7 tertiary centers. Most HCCCs (91%) originated from minor salivary glands, although major salivary glands were affected in 8%. The most common sites were base of tongue, palate, nasopharynx, and maxilla. Eosinophilic cells were more prevalent than clear cells. Histologic features included intraosseous component (19%), perineural invasion (48%), lymphovascular invasion (LVI, 16%), nuclear pleomorphism (14%), tumor necrosis (26%), and a mitotic index (MI) ≥ 5/2 mm2 (9%). Factors associated with increased risk of nodal metastasis at presentation included LVI, high MI, and tumor necrosis. The 10-year disease-specific survival (DSS), disease-free survival (DFS), and distant metastasis-free survival (DMFS) rates were 80%, 51%, and 87%, respectively. Significant prognostic factors identified on univariate survival analysis included MI ≥ 5/2 mm2, tumor necrosis, atypical mitosis, and nuclear pleomorphism for DSS; LVI, MI ≥ 5/2 mm2, and percentage of clear cells for DFS; and nodal metastasis, LVI, MI ≥ 5/2 mm2, tumor necrosis, and atypical mitosis for DMFS. The only independent prognostic factor for DFS identified on multivariate survival analysis was MI ≥ 5/2 mm2. High-grade HCCCs, defined as tumors with MI ≥ 5/2 mm2 and/or tumor necrosis, were associated with an increased risk of nodal metastasis at presentation and shortened DSS and DMFS. Among 67 HCCCs examined for EWSR1 rearrangement, 65 (97%) harbored EWSR1 translocation. In conclusion, we identified multiple prognostic factors in HCCC, including MI, necrosis, atypical mitosis, nuclear pleomorphism, LVI, and percentage of clear cells. We herein proposed a prognostically relevant 2-tiered grading system, classifying HCCC with a MI ≥ 5/10 2 mm2 and/or tumor necrosis as high grade.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Adenocarcinoma, Clear CellSalivary Gland NeoplasmsHead and Neck NeoplasmsHumansFemaleMaleRetrospective StudiesMiddle AgedAgedAdultNeoplasm GradingPrognosisAged, 80 and overYoung AdultDisease-Free SurvivalHyalinAdolescent

Stichwörter der Autor:innen

EWSR1 translocationhyalinizing clear cell carcinomaprognosissalivary gland carcinoma

Autor:innen und Institutionen

  • Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Department of Pathology and Laboratory Medicine, School of Medicine, Emory University, Atlanta, Georgia.
  • Department of Pathology, Centre Hospitalier Universitaire Vaudois, Switzerland.
  • Department of Anatomic Pathology, Yale School of Medicine, New Haven, Connecticut.
  • Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland.
  • Department of Pathology, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania.

Förderung

  • NCI NIH HHS
  • National Institutes of Health
  • National Institutes of Health National Cancer Institute

Zitieren

APA

Xu, B., Viswanathan, K., Barbesier, M., Ladenheim, A., Antonescu, C. R., Ghossein, R., Lubin, D., Magliocca, K., Matar, S., Mikula, M. W., Resta, I. T., Roy, D., Sohn, S. Y., Verma, A., Prasad, M. L., Rooper, L., Brandwein-Weber, M., Baloch, Z., & Katabi, N. (2025). Hyalinizing Clear Cell Carcinoma of the Head and Neck: A Multicenter Retrospective Study of 87 Cases Focusing on Prognostic Pathologic Features and Grading Scheme. Modern Pathology. https://doi.org/10.1016/j.modpat.2025.100834

Vancouver

Xu B, Viswanathan K, Barbesier M, Ladenheim A, Antonescu CR, Ghossein R, et al. Hyalinizing Clear Cell Carcinoma of the Head and Neck: A Multicenter Retrospective Study of 87 Cases Focusing on Prognostic Pathologic Features and Grading Scheme. Modern Pathology. 2025. doi:10.1016/j.modpat.2025.100834

BibTeX
@article{Xu2025,
  author = {Xu, Bin and Viswanathan, Kartik and Barbesier, Marie and Ladenheim, Alexander and Antonescu, Cristina R and Ghossein, Ronald and Lubin, Dan and Magliocca, Kelly and Matar, Sayed and Mikula, Michael W and Resta, Isabella Tondi and Roy, Dibisha and Sohn, Soo Yeon and Verma, Anuj and Prasad, Manju L and Rooper, Lisa and Brandwein-Weber, Margaret and Baloch, Zubair and Katabi, Nora},
  title = {Hyalinizing Clear Cell Carcinoma of the Head and Neck: A Multicenter Retrospective Study of 87 Cases Focusing on Prognostic Pathologic Features and Grading Scheme},
  journal = {Modern Pathology},
  year = {2025},
  doi = {10.1016/j.modpat.2025.100834}
}
Kostenlos starten →